This topic is empty. Viewing 1 post (of 1 total) Author Posts 10/05/2020 at 9:17 am #11090 Colorado BioScience AssociationKeymaster The company submitted an Investigational New Drug (IND) application with the U.S. FDA to evaluate its AB201 for the treatment of patients hospitalized with COVID-19. More Information Author Posts Viewing 1 post (of 1 total) You must be logged in to reply to this topic. Log In Username: Password: Keep me signed in Want an easier way to login? Get a magic link sent to your email that will sign you in instantly! Email Magic Link Or Login with username and password Login with a Magic Link For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.I agree to these terms. Log In